SCHEMBL7376736

SCHEMBL7376736

[CH2]c1cccc(-c2nc(NC)c[nH]2)c1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 1/20 0.33
▸ MAOB P27338 2/20 0.33
▸ PLCG1 P19174 1/20 0.32
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ BPTF Q12830 1/20 0.31
▸ MAP4K4 O95819 2/20 0.30
▸ NTRK1 P04629 1/20 0.30
▸ CNR1 P21554 1/20 0.30
▸ CXCR2 P25025 1/20 0.30
▸ MGAM O43451 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ SI P14410 1/20 0.30
▸ MGAM2 Q2M2H8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371967 0.84 GABRG2 (0.35) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7376433 0.79 GAA (0.37) MGAMGAASIMGAM2
SCHEMBL7379613 0.75 TDO2 (0.35) TDO2GABRA1GABRG2GABRB3GABRA5
SCHEMBL7377289 0.72 KMT2A (0.35) CNR1MGAMGAASIMGAM2
SCHEMBL7377830 0.69 HRH1 (0.39) MAP4K4CNR1
SCHEMBL7376460 0.66 NPY5R (0.45) MGAMGAASIMGAM2
SCHEMBL7377393 0.65 NISCH (0.60) —
SCHEMBL27306195 0.65 ALDH1A1 (0.50) TDP1GAA
SCHEMBL7372548 0.65 RORC (0.41) —
SCHEMBL27518113 0.62 NTRK1 (0.43) TDP1NTRK1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 — — WO claimed
US-5763469-A Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-06-09 — — US disclosed
WO-1997008150-A1 SUBSTITUTED CYCLIC UREAS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-06 — — WO disclosed
Send feedback